ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

CERT Certara Inc

17.60
-0.01 (-0.06%)
May 03 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Certara Inc CERT NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.01 -0.06% 17.60 19:00:00
Open Price Low Price High Price Close Price Previous Close
17.93 17.45 17.94 17.60 17.61
more quote information »

Recent News

Date Time Source Heading
4/16/202407:00GLOBECertara Launches Cloud Platform to Further Unify its..
4/09/202415:15GLOBECertara to Report First Quarter 2024 Financial Results on..
3/06/202415:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/06/202415:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/06/202415:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202415:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/04/202418:26EDGAR2Form 144 - Report of proposed sale of securities
2/29/202415:30EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/29/202415:21EDGAR2Form 8-K - Current report
2/29/202415:10GLOBECertara Reports Fourth Quarter 2023 Financial Results
2/21/202415:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/20/202411:25EDGAR2Form 144 - Report of proposed sale of securities
2/14/202415:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/12/202416:14EDGAR2Form 144 - Report of proposed sale of securities
2/01/202415:30GLOBECertara to Report Fourth Quarter and Full Year 2023..
12/27/202317:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/26/202311:22EDGAR2Form 144 - Report of proposed sale of securities
12/13/202315:30GLOBECertara Acquires Applied BioMath Expanding Its Biosimulation..
11/21/202315:30GLOBECertara introduces Simcyp™ Biopharmaceutics software to..
11/08/202315:32EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/08/202315:16EDGAR2Form 8-K - Current report
11/08/202315:10GLOBECertara Reports Third Quarter 2023 Financial Results
10/11/202315:15GLOBECertara to Report Third Quarter 2023 Financial Results on..
10/06/202316:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/19/202307:15GLOBECertara Announces 300th Regulatory Submission Milestone..
8/29/202315:15GLOBECertara to Participate in Upcoming Investor Conferences
8/29/202307:15GLOBECertara Simcyp™ Group Awarded Two New Grants from US FDA
8/09/202315:22EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/09/202315:15GLOBECertara Reports Second Quarter 2023 Financial Results
8/09/202315:11EDGAR2Form 8-K - Current report
8/03/202320:00BWCertara collaborates with Korea Institute of Toxicology to..
8/02/202315:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/13/202315:30GLOBECertara to Report Second Quarter 2023 Financial Results on..
7/03/202316:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/02/202315:15GLOBECertara to Participate in the Jefferies Global Healthcare..
5/08/202315:15GLOBECertara Reports First Quarter 2023 Financial Results

Your Recent History

Delayed Upgrade Clock